Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Telehealth and eHealth

 

Ada Health building diagnostic results into its app

In the peak of Germany's pandemic, symptom-checker app Ada Health rapidly built a solution to digitally return COVID-19 test results to a lab's customers. Founder Claire Novorol tells HBI that the new capability is part of a long term strategy that will allow the company to better incorporate diagnostic data into its app.
September 3, 2020

XenZone lists on AIM and rebrands as Kooth

Digital mental health group XenZone has listed on the small-cap AIM exchange, raising £16m. Its CEO tells HBI that the company is targeting entry to the US and Europe. It has also rebranded as Kooth, its main brand name.
September 3, 2020

Interview: Nasser Al Hagbani, CEO, Dr. Sulaiman Al Habib Medical Services Group

Saudi/UAE hospital operator Dr. Sulaiman Al Habib Medical Services Group (HmG) is by far the largest player by revenue in the GCC at $1.3bn. Shares have all but doubled since its IPO in March, making it the sixth-largest hospital stock globally by market capitalisation at $8.5bn. Its lucrative tele-ICU centre is the largest in the world by beds monitored. In this exclusive interview, Hagbani discusses HmG's listing, business model, Saudisation efforts, declining expat market and of course COVID-19.
September 2, 2020

KRY gets reimbursement in Germany as Docly all but leaves UK

Sweden's largest telehealth player KRY will be reimbursed in Germany after it received the necessary security accreditation. Meanwhile, Docly, the spin-off from Sweden's once largest player Min Doktor, has just withdrawn its healthcare services from its only international market following slow growth.
August 20, 2020

Benelux countries make moves on digital therapy reimbursement

The Netherlands and Belgium are closely following behind Germany in reimbursing digital therapeutics (DTx). Payors in the former are negotiating a strategy while the latter has just seen a rehabilitation app become the first to receive public payment. 
July 30, 2020

Interview: Pablo Pantaleoni, VP of global strategy, Headspace

Headspace started a decade ago as a meditation app founded by a Buddhist monk. It is now one of the world's most successful consumer B2C businesses with 65m downloads, 2m paying subscribers and north of $50m revenue. HBI speaks to Pablo Pantaleoni who is leading the early stages of clinical trials for digital therapeutics (DTx) through its medical subsidiary, Headspace Health.
July 30, 2020

Kaia Health eyeing France and UK launch

German digital therapeutics (DTx) app Kaia Health tells HBI it will soon launch in France and the UK after completing Europe's largest randomised control trial (RCT) for DTx focused on a chronic disease. 
July 23, 2020
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us